SLAMF7 Antikörper (AA 23-226)
Kurzübersicht für SLAMF7 Antikörper (AA 23-226) (ABIN7169786)
Target
Alle SLAMF7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 23-226
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human SLAM family member 7 protein (23-226AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SLAMF7 (SLAM Family Member 7 (SLAMF7))
-
Andere Bezeichnung
- SLAMF7
-
Hintergrund
-
Background: Isoform 1 mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway. May play a role in lymphocyte adhesion. Isoform 3 does not mediate any NK cell activation.
Aliases: SLAMF7 antibody, CS1 antibody, UNQ576/PRO1138 antibody, SLAM family member 7 antibody, CD2 subset 1 antibody, CD2-like receptor-activating cytotoxic cells antibody, CRACC antibody, Membrane protein FOAP-12 antibody, Novel Ly9 antibody, Protein 19A antibody, CD antigen CD319 antibody
-
UniProt
- Q9NQ25
Target
-